Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Aetna Inc. stock logo
AET
Aetna
$212.70
$212.70
$166.88
$213.36
$69.64B0.713.69 million shs11.86 million shs
CORO
iShares International Country Rotation Active ETF
$27.51
-0.4%
$25.66
$22.54
$27.63
$6.60MN/A864 shs6,894 shs
Pharming Group stock logo
PHAR
Pharming Group
$11.61
+9.5%
$9.06
$6.65
$12.39
$789.77M-0.086,446 shs5,362 shs
A Beginner's Guide to Investing in Cannabis Cover

Unlock your free copy of MarketBeat's comprehensive guide to pot stock investing and discover which cannabis companies are poised for growth. Plus, you'll get exclusive access to our daily newsletter with expert stock recommendations from Wall Street's top analysts.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Aetna Inc. stock logo
AET
Aetna
0.00%0.00%0.00%0.00%0.00%
CORO
iShares International Country Rotation Active ETF
-0.36%0.00%+3.67%+5.93%+2,750,999,900.00%
Pharming Group stock logo
PHAR
Pharming Group
+1.12%+7.64%+28.72%+31.03%+21.69%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Aetna Inc. stock logo
AET
Aetna
N/AN/AN/AN/AN/AN/AN/AN/A
CORO
iShares International Country Rotation Active ETF
N/AN/AN/AN/AN/AN/AN/AN/A
Pharming Group stock logo
PHAR
Pharming Group
2.573 of 5 stars
3.55.00.00.02.00.00.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Aetna Inc. stock logo
AET
Aetna
0.00
N/AN/AN/A
CORO
iShares International Country Rotation Active ETF
2.79
Moderate Buy$27.51N/A
Pharming Group stock logo
PHAR
Pharming Group
3.00
Buy$30.00158.42% Upside

Current Analyst Ratings Breakdown

Latest CORO, AET, ZPHR, and PHAR Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
3/20/2025
Pharming Group stock logo
PHAR
Pharming Group
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00 ➝ $37.00
3/14/2025
Pharming Group stock logo
PHAR
Pharming Group
Oppenheimer
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Boost Price TargetOutperform ➝ Outperform$30.00 ➝ $39.00
3/14/2025
Pharming Group stock logo
PHAR
Pharming Group
HC Wainwright
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy$37.00 ➝ $37.00
(Data available from 6/4/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Aetna Inc. stock logo
AET
Aetna
$60.54B1.15$12.44 per share17.10$56.70 per share3.75
CORO
iShares International Country Rotation Active ETF
N/AN/AN/AN/AN/AN/A
Pharming Group stock logo
PHAR
Pharming Group
$320.71M2.46$0.13 per share91.82$3.26 per share3.56
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Aetna Inc. stock logo
AET
Aetna
$1.90B$9.8621.5717.151.825.99%20.78%6.22%N/A
CORO
iShares International Country Rotation Active ETF
N/AN/A0.00N/AN/AN/AN/AN/A
Pharming Group stock logo
PHAR
Pharming Group
-$10.55M-$0.20N/A386.97N/A-6.09%-7.65%-3.82%7/30/2025 (Estimated)

Latest CORO, AET, ZPHR, and PHAR Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/8/2025Q1 2025
Pharming Group stock logo
PHAR
Pharming Group
-$0.25-$0.22+$0.03-$0.22$67.74 million$79.09 million
3/13/2025Q4 2024
Pharming Group stock logo
PHAR
Pharming Group
$0.07$0.05-$0.02$0.05$76.67 million$92.70 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Aetna Inc. stock logo
AET
Aetna
$2.000.94%N/A20.28%N/A
CORO
iShares International Country Rotation Active ETF
$0.361.31%N/AN/AN/A
Pharming Group stock logo
PHAR
Pharming Group
N/AN/AN/AN/AN/A
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Aetna Inc. stock logo
AET
Aetna
0.42
0.79
0.79
CORO
iShares International Country Rotation Active ETF
N/AN/AN/A
Pharming Group stock logo
PHAR
Pharming Group
0.41
3.53
2.76

Institutional Ownership

CompanyInstitutional Ownership
Aetna Inc. stock logo
AET
Aetna
82.34%
CORO
iShares International Country Rotation Active ETF
N/A
Pharming Group stock logo
PHAR
Pharming Group
0.03%

Insider Ownership

CompanyInsider Ownership
Aetna Inc. stock logo
AET
Aetna
1.21%
CORO
iShares International Country Rotation Active ETF
N/A
Pharming Group stock logo
PHAR
Pharming Group
2.07%
CompanyEmployeesShares OutstandingFree FloatOptionable
Aetna Inc. stock logo
AET
Aetna
N/A327.40 millionN/AOptionable
CORO
iShares International Country Rotation Active ETF
N/A240,000N/AN/A
Pharming Group stock logo
PHAR
Pharming Group
28068.03 million66.62 millionNot Optionable

Recent News About These Companies

Pharming Group (NASDAQ:PHAR) Shares Up 10.1% - Should You Buy?

New MarketBeat Followers Over Time

Media Sentiment Over Time

Aetna stock logo

Aetna NYSE:AET

Aetna Inc. operates as a health care benefits company in the United States. It operates through three segments: Health Care, Group Insurance, and Large Case Pensions. The Health Care segment offers medical, pharmacy benefit management service, dental, behavioral health, and vision plans on an insured and employer-funded basis. It also provides point-of-service, preferred provider organization, health maintenance organization, and indemnity benefit plans, as well as health savings accounts and consumer-directed health plans. In addition, this segment offers Medicare and Medicaid products and services, as well as other medical products, such as medical management and data analytics services, medical stop loss insurance, workers' compensation administrative services, and products that provide access to its provider networks in select geographies. The Group Insurance segment offers life insurance products, including group term life insurance, voluntary spouse and dependent term life insurance, group universal life insurance, and accidental death and dismemberment insurance; disability insurance products; and long-term care insurance products, which provide the benefits to cover the cost of care in private home settings, adult day care, assisted living, or nursing facilities. The Large Case Pensions segment manages various retirement products comprising pension and annuity products primarily for tax-qualified pension plans. The company provides its products and services to employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates. Aetna Inc. was founded in 1853 and is based in Hartford, Connecticut.

iShares International Country Rotation Active ETF NASDAQ:CORO

$27.51 -0.10 (-0.36%)
As of 06/3/2025 03:12 PM Eastern

The iShares International Country Rotation Active ETF (CORO) is an exchange-traded fund that mostly invests in total market equity. The fund is an actively managed fund-of-funds, seeking long-term capital appreciation through investments in non-US companies. The fund targets nations with favorable economic outlooks by employing a country rotation strategy. CORO was launched on Dec 3, 2024 and is issued by BlackRock.

Pharming Group stock logo

Pharming Group NASDAQ:PHAR

$11.61 +1.01 (+9.52%)
Closing price 06/3/2025 03:57 PM Eastern
Extended Trading
$12.39 +0.78 (+6.69%)
As of 09:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Pharming Group N.V., a biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally. The company offers RUCONEST, a recombinant C1 esterase inhibitor for the treatment of acute attacks in adult and adolescent patients with acute hereditary angioedema (HAE); and Joenja (leniolisib), an oral small molecule PI3K? inhibitor for the treatment of activated phosphoinositide 3-kinase delta syndrome. It also develops OTL-105, an investigational ex-vivo autologous hematopoietic stem cell gene therapy for the treatment of HAE. The company has a development collaboration and license agreement with Novartis; and a strategic collaboration agreement with Orchard Therapeutics plc for research, development, manufacturing, and commercialization of OTL-105. Pharming Group N.V. was incorporated in 1988 and is headquartered in Leiden, the Netherlands.